Display options
Share it on

Neuropsychiatr Dis Treat. 2016 Jul 11;12:1705-10. doi: 10.2147/NDT.S107074. eCollection 2016.

Cortical spreading depression produces a neuroprotective effect activating mitochondrial uncoupling protein-5.

Neuropsychiatric disease and treatment

Emanuela Viggiano, Vincenzo Monda, Antonietta Messina, Fiorenzo Moscatelli, Anna Valenzano, Domenico Tafuri, Giuseppe Cibelli, Bruno De Luca, Giovanni Messina, Marcellino Monda

Affiliations

  1. Department of Experimental Medicine, Section of Human Physiology and Unit of Dietetics and Sports Medicine, Second University of Naples, Naples; Department of Medicine, University of Padua, Padua.
  2. Department of Experimental Medicine, Section of Human Physiology and Unit of Dietetics and Sports Medicine, Second University of Naples, Naples.
  3. Department of Clinical and Experimental Medicine, University of Foggia, Foggia.
  4. Department of Motor Sciences and Wellness, University of Naples "Parthenope", Naples, Italy.
  5. Department of Experimental Medicine, Section of Human Physiology and Unit of Dietetics and Sports Medicine, Second University of Naples, Naples; Department of Clinical and Experimental Medicine, University of Foggia, Foggia.

PMID: 27468234 PMCID: PMC4946829 DOI: 10.2147/NDT.S107074

Abstract

Depression of electrocorticogram propagating over the cortex surface results in cortical spreading depression (CSD), which is probably related to the pathophysiology of stroke, epilepsy, and migraine. However, preconditioning with CSD produces neuroprotection to subsequent ischemic episodes. Such effects require the expression or activation of several genes, including neuroprotective ones. Recently, it has been demonstrated that the expression of the uncoupling proteins (UCPs) 2 and 5 is amplified during brain ischemia and their expression exerts a long-term effect upon neuron protection. To evaluate the neuroprotective consequence of CSD, the expression of UCP-5 in the brain cortex was measured following CSD induction. CSD was evoked in four samples of rats, which were sacrificed after 2 hours, 4 hours, 6 hours, and 24 hours. Western blot analyses were carried out to measure UCP-5 concentrations in the prefrontal cortices of both hemispheres, and immunohistochemistry was performed to determine the localization of UCP-5 in the brain cortex. The results showed a significant elevation in UCP-5 expression at 24 hours in all cortical strata. Moreover, UCP-5 was triggered by CSD, indicating that UCP-5 production can have a neuroprotective effect.

Keywords: cortical spreading depression; neuroprotective effect; uncoupling protein-5

References

  1. Stroke. 1999 Jan;30(1):114-9 - PubMed
  2. Electroencephalogr Clin Neurophysiol. 1951 Aug;3(3):315-21 - PubMed
  3. Neurol Res. 1995 Feb;17(1):9-16 - PubMed
  4. J Cereb Blood Flow Metab. 2011 Jan;31(1):17-35 - PubMed
  5. Brain Res. 1988 May 24;449(1-2):395-8 - PubMed
  6. Brain Res. 2010 May 6;1329:1-9 - PubMed
  7. Chemosphere. 2014 Jan;94:62-9 - PubMed
  8. Front Psychol. 2014 Sep 08;5:997 - PubMed
  9. Free Radic Res Commun. 1991;14(3):159-71 - PubMed
  10. J Cell Mol Med. 2008 Dec;12(6B):2731-53 - PubMed
  11. Neural Plast. 2015;2015:265967 - PubMed
  12. Actual Neurophysiol (Paris). 1962;4:107-24 - PubMed
  13. Brain. 2006 Mar;129(Pt 3):778-90 - PubMed
  14. Trends Biochem Sci. 1993 Nov;18(11):437-41 - PubMed
  15. Am J Physiol. 1993 Feb;264(2 Pt 2):R456-9 - PubMed
  16. Neuroscience. 2010 Mar 17;166(2):416-21 - PubMed
  17. Brain Res. 2011 Jan 12;1368:11-8 - PubMed
  18. Auton Neurosci. 2012 Aug 16;169(2):102-6 - PubMed
  19. Eur J Neurosci. 2004 Apr;19(7):1708-20 - PubMed
  20. Anesthesiology. 1997 Oct;87(4):918-25 - PubMed
  21. Clin Nutr. 2008 Aug;27(4):657-9 - PubMed
  22. Exp Neurol. 1984 May;84(2):249-58 - PubMed
  23. Nat Genet. 2000 Dec;26(4):435-9 - PubMed
  24. Brain Res. 2000 Sep 22;877(2):331-44 - PubMed
  25. Stem Cell Res Ther. 2014 Jan 09;5(1):4 - PubMed
  26. J Cereb Blood Flow Metab. 2012 Aug;32(8):1632-42 - PubMed
  27. J Cereb Blood Flow Metab. 1995 Sep;15(5):721-7 - PubMed
  28. Front Aging Neurosci. 2014 Mar 18;6:44 - PubMed
  29. Brain Res. 2012 Jul 27;1467:113-9 - PubMed
  30. Stroke. 1995 Jun;26(6):1047-52 - PubMed
  31. Neuropathology. 2007 Oct;27(5):442-7 - PubMed
  32. J Diabetes Complications. 2009 Mar-Apr;23(2):119-23 - PubMed
  33. Neurochem Res. 2014 Dec;39(12):2431-9 - PubMed
  34. Exp Neurol. 1999 Dec;160(2):317-32 - PubMed
  35. Neuroscience. 2008 Apr 22;153(1):182-8 - PubMed
  36. Brain Res. 1998 Feb 9;783(2):188-93 - PubMed
  37. Eur J Neurosci. 2006 Aug;24(3):841-56 - PubMed
  38. Biochem Pharmacol. 2003 Jun 15;65(12 ):1917-21 - PubMed
  39. Oxid Med Cell Longev. 2014;2014:131024 - PubMed
  40. Brain Res Mol Brain Res. 2002 Feb 28;99(1):75-81 - PubMed
  41. J Cereb Blood Flow Metab. 2003 Jul;23(7):786-810 - PubMed
  42. J Cereb Blood Flow Metab. 2003 Jan;23(1):43-50 - PubMed
  43. Genomics. 2010 Aug;96(2):82-91 - PubMed
  44. J Cereb Blood Flow Metab. 1997 Jul;17(7):781-90 - PubMed
  45. Brain Res. 1998 Oct 5;807(1-2):47-60 - PubMed
  46. J Cereb Blood Flow Metab. 1998 Jan;18(1):75-87 - PubMed
  47. PLoS One. 2012;7(12):e50985 - PubMed
  48. Psychiatry Investig. 2008 Dec;5(4):203-8 - PubMed
  49. Brain Res. 2004 Sep 3;1019(1-2):178-88 - PubMed

Publication Types